Related content

The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers

By Jakubowska Anna   Rozkrut Dominik   Antoniou Antonis   Hamann Ute   Lubinski Jan  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 639-649

Springer Publishing Company

Access to resources Recommend Favorite

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

By  

The Women's Oncology Review, Vol. 4, Iss. 3, 2004-09 ,pp. : 241-242

Informa Healthcare

Access to resources Recommend Favorite

Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study

By Lindor Noralane  

Familial Cancer, Vol. 9, Iss. 4, 2010-12 ,pp. : 495-502

Springer Publishing Company

Access to resources Recommend Favorite

Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers

By Bernholtz Shiri  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 981-985

Springer Publishing Company

Access to resources Recommend Favorite

Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers

By Baeyens A.   Thierens H.   Claes K.   Poppe B.   Ridder L. De   Vral A.  

International Journal of Radiation Biology, Vol. 80, Iss. 10, 2004-10 ,pp. : 745-756

Informa Healthcare

Access to resources Recommend Favorite